Hormonal, Metabolic, and Signaling Interactions in PAH
Vanderbilt University Medical Center · NCT01884051
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1899
- US sites recruiting
- 1
- Study start
- September 2012
- Record last updated
- September 25, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Our hypothesis is that optimal treatment of the dysfunctional metabolic pathways which underlie PAH will improve pulmonary vascular function and consequences of the disease.
Conditions: Idiopathic Pulmonary Arterial Hypertension; Heritable Pulmonary Arterial Hypertension; Scleroderma Associated Pulmonary Arterial Hypertension; Appetite Suppressant Associate PAH
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Project 1
Inclusion
- Diagnosis of IPAH (idiopathic pulmonary arterial hypertension), HPAH (heritable pulmonary arterial hypertension), or APAH (associated pulmonary arterial hypertension), family members of affected persons
- Age 0-90, age 12-90 for skin biopsy
Exclusion
- Other diagnosis
- Age greater than 90, age less than 12 or greater than 90 for skin biopsy
Project 2
Inclusion
- Diagnosis of IPAH, HPAH, or APAH, family members of affected persons
- 0-90
- Subjects with reasonably easy access to clinic for blood collection and other testing
- Subject able to tolerate fasting state prior to sample collection and EndoPAT (endothelial function assessment) testing
Exclusion
- Other diagnosis
- 0-90
- Subjects with difficulty reaching clinic for blood collection and other testing
- Subjects unable to tolerate fasting state
Project 3
Inclusion
- Diagnosis of IPAH, HPAH, or APAH, family members of affected persons
- 7-90
Exclusion
- Other diagnosis
- Age less than 7 or greater than 90
-
Exclusion Criteria
-
Recruiting US locations
Vanderbilt University Medical Center
Nashville, TN 37232
Study contacts (from the official record)
- Kelly L Fox · 800-288-0378 · Kelly.Burke@vumc.org
- Shannon Cordell, BSN · 615-343-8277 · shannon.eason@vumc.org
Similar studies in Tennessee
All heart & blood pressure studies in Tennessee →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Knoxville, TN + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Nashville, TN + 30 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform
Idoven 1903 S.L.
- Location
- Nashville, TN
- Eligibility basics
- Ages 18+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Germantown, TN + 64 other US sites
- Eligibility basics
- Ages 18+